Galmed Pharmaceuticals:因协议终止,授权技术全部权利将归还Yissum

美股速递
Jul 30

Galmed Pharmaceuticals宣布,由于协议终止,所有与授权技术相关的权利将悉数返还给Yissum。这一决定,标志着双方合作关系的正式终结,同时也意味着相关技术资产的归属权将发生根本性变更。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10